Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Biotika AS's Enterprise Value is €11.68 Mil.
Biotika AS's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was €0.56 Mil. Therefore, Biotika AS's EV-to-EBIT ratio for today is 20.78.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Biotika AS's Enterprise Value is €11.68 Mil.
Biotika AS's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was €1.30 Mil. Therefore, Biotika AS's EV-to-EBITDA ratio for today is 8.96.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Biotika AS's Enterprise Value is €11.68 Mil.
Biotika AS's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was €9.28 Mil. Therefore, Biotika AS's EV-to-Revenue ratio for today is 1.26.
Biotika AS Enterprise Value Historical Data
The historical data trend for Biotika AS's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Biotika AS's Enterprise Value
For the Drug Manufacturers - Specialty & Generic subindustry, Biotika AS's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biotika AS's Enterprise Value Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Biotika AS's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Biotika AS's Enterprise Value falls into.
Biotika AS Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Biotika AS's Enterprise Value for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biotika AS (XBRA:1BSL01AE) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Biotika AS's current Enterprise Value is €11.68 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Biotika AS's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was €0.56 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Biotika AS's current Enterprise Value is €11.68 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Biotika AS's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was €1.30 Mil.
Biotika AS's current Enterprise Value is €11.68 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Biotika AS's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was €9.28 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biotika AS Enterprise Value Related Terms
Thank you for viewing the detailed overview of Biotika AS's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Biotika AS is a manufacturer of pharmaceutical preparations for the human and veterinary application. It is engaged in the production of Active Pharmaceutical Ingredients (API), contract manufacturing of API, and contract manufacturing of final dosage formulations. It also offers research and development services. It manufacturers Polymyxine B Sulfate and other API for third parties (toll manufacturing) of pharmaceutical quality. Biotika is well known as a reliable manufacturer of high-quality pharmaceutical preparations for the human as well as veterinary application and also as a very important producer of the feed additives for breeding farm animals.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XBRA:1BSL01AE has been successfully added to your 